C2orf92
gene geneOn this page
Summary
C2orf92 (chromosome 2 open reading frame 92, HGNC:49272) is a protein-coding gene on chromosome 2q11.2, encoding Uncharacterized protein C2orf92 (A0A1B0GVN3).
Predicted to be located in membrane.
Source: NCBI Gene 728537 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001351368
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49272 |
| Approved symbol | C2orf92 |
| Name | chromosome 2 open reading frame 92 |
| Location | 2q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000228486 |
| Ensembl biotype | protein_coding |
| Entrez | 728537 |
Gene structure
Transcript identifiers
Ensembl transcripts: 58 — 34 protein_coding_CDS_not_defined, 12 nonsense_mediated_decay, 6 retained_intron, 6 protein_coding
ENST00000428157, ENST00000445382, ENST00000450072, ENST00000451384, ENST00000458149, ENST00000594273, ENST00000595492, ENST00000595588, ENST00000596069, ENST00000596356, ENST00000596529, ENST00000596740, ENST00000597654, ENST00000597941, ENST00000598144, ENST00000598737, ENST00000598824, ENST00000599015, ENST00000599435, ENST00000599501, ENST00000599666, ENST00000599959, ENST00000600331, ENST00000600606, ENST00000601127, ENST00000601499, ENST00000601509, ENST00000601580, ENST00000603172, ENST00000603835, ENST00000604793, ENST00000604986, ENST00000605017, ENST00000605282, ENST00000605331, ENST00000605866, ENST00000608777, ENST00000609004, ENST00000609295, ENST00000609418, ENST00000609604, ENST00000609622, ENST00000609703, ENST00000615201, ENST00000615478, ENST00000627012, ENST00000627137, ENST00000627284, ENST00000627399, ENST00000628093, ENST00000628434, ENST00000628992, ENST00000629840, ENST00000629956, ENST00000630068, ENST00000630892, ENST00000631206, ENST00000631224
RefSeq mRNA: 2 — MANE Select: NM_001351368
NM_001351368, NM_001410919
CCDS: CCDS86862, CCDS92816
Canonical transcript exons
ENST00000627399 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003793290 | 97675845 | 97675928 |
| ENSE00003794078 | 97699026 | 97699136 |
| ENSE00003796519 | 97690256 | 97690327 |
| ENSE00003798309 | 97701154 | 97701304 |
| ENSE00003800198 | 97688895 | 97688993 |
| ENSE00003801052 | 97674456 | 97674557 |
| ENSE00003927701 | 97702669 | 97703066 |
| ENSE00003929384 | 97669713 | 97669834 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 94.29.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4021 / max 55.2226, expressed in 614 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21512 | 0.9956 | 476 |
| 21513 | 0.3739 | 203 |
| 21514 | 0.0235 | 3 |
| 21515 | 0.0091 | 3 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.29 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.23 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 92.74 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 92.68 | gold quality |
| left testis | UBERON:0004533 | 92.48 | gold quality |
| right testis | UBERON:0004534 | 92.35 | gold quality |
| body of pancreas | UBERON:0001150 | 92.17 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.17 | gold quality |
| cerebellar cortex | UBERON:0002129 | 91.88 | gold quality |
| thyroid gland | UBERON:0002046 | 91.42 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 90.68 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.51 | gold quality |
| right lung | UBERON:0002167 | 89.08 | gold quality |
| testis | UBERON:0000473 | 89.03 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.95 | gold quality |
| cerebellum | UBERON:0002037 | 88.92 | gold quality |
| minor salivary gland | UBERON:0001830 | 88.16 | gold quality |
| right lobe of liver | UBERON:0001114 | 88.15 | gold quality |
| tibial nerve | UBERON:0001323 | 87.86 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.85 | gold quality |
| skin of abdomen | UBERON:0001416 | 87.60 | gold quality |
| apex of heart | UBERON:0002098 | 87.56 | gold quality |
| endocervix | UBERON:0000458 | 87.55 | gold quality |
| mucosa of stomach | UBERON:0001199 | 86.98 | gold quality |
| skin of leg | UBERON:0001511 | 86.89 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.84 | gold quality |
| spleen | UBERON:0002106 | 86.68 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 86.43 | gold quality |
| ectocervix | UBERON:0012249 | 86.32 | gold quality |
| spinal cord | UBERON:0002240 | 86.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.59 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment. (PMID:33928340)
- m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer. (PMID:37824376)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 4933424G06Rik | ENSMUSG00000102416 |
| rattus_norvegicus | C9h2orf92 | ENSRNOG00000052570 |
Protein
Protein identifiers
Uncharacterized protein C2orf92 — A0A1B0GVN3 (reviewed: A0A1B0GVN3)
Alternative names: Long intergenic non-protein coding RNA 1125
All UniProt accessions (15): A0A1B0GTH1, A0A1B0GTX5, A0A1B0GUD5, A0A1B0GUG7, A0A1B0GUK5, A0A1B0GV62, A0A1B0GVE2, A0A1B0GVN3, A0A1B0GVP0, A0A1B0GVT1, A0A1B0GW71, A0A1B0GW88, A0A1B0GWB7, A0A1B0GWI3, A0A1B0GWK3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (2): NP_001338297, NP_001397848 (=MANE)
Domains & families (InterPro)
UniProt features (3 total): signal peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GVN3-F1 | 54.22 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, chr2q11, ARID5B_TARGET_GENES, CIITA_TARGET_GENES, EBNA1BP2_TARGET_GENES, FOXN3_TARGET_GENES, HAND1_TARGET_GENES, PAX3_TARGET_GENES, RBM34_TARGET_GENES, SRSF9_TARGET_GENES, SUPT16H_TARGET_GENES, UBN1_TARGET_GENES, ZFP91_TARGET_GENES, ZNF274_TARGET_GENES, ZNF362_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
10 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C2orf92 | C10orf120 | Q5SQS8 | 815 |
| C2orf92 | PPP1R36 | Q96LQ0 | 720 |
| C2orf92 | PPP3CC | P48454 | 480 |
| C2orf92 | MEST | Q5EB52 | 222 |
| C2orf92 | DDX4 | Q9NQI0 | 219 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GVN3, A0A482APM8, A1KXM5, A4H257, A4H258, A4H259, A4H260, A6H7F9, A6NFE2, A6NHS7, A7KBS4, E9Q7F5, O74981, O75969, P09258, P09558, P19442, P22575, P80195, P88825, Q00997, Q04547, Q05100, Q2LCV6, Q2M2T8, Q30KK0, Q5NRP9, Q5QR91, Q5RAW4, Q5RBQ2, Q5RII3, Q6AXV6, Q6AXY9, Q6UW49, Q77NN4, Q7Z9I5, Q80YD3, Q810S2, Q8N4C9, Q95LJ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1756 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:97702700:T:C | F233L | 0.956 |
| 2:97702702:T:A | F233L | 0.956 |
| 2:97702702:T:G | F233L | 0.956 |
| 2:97701199:T:C | L187P | 0.925 |
| 2:97701195:T:C | F186L | 0.921 |
| 2:97701197:C:A | F186L | 0.921 |
| 2:97701197:C:G | F186L | 0.921 |
| 2:97688901:T:C | I80T | 0.915 |
| 2:97688901:T:G | I80S | 0.904 |
| 2:97702726:G:C | W241C | 0.872 |
| 2:97702726:G:T | W241C | 0.872 |
| 2:97675880:T:C | F62L | 0.863 |
| 2:97675882:T:A | F62L | 0.863 |
| 2:97675882:T:G | F62L | 0.863 |
| 2:97675925:T:C | F77L | 0.863 |
| 2:97675927:T:A | F77L | 0.863 |
| 2:97675927:T:G | F77L | 0.863 |
| 2:97674476:T:C | F23L | 0.861 |
| 2:97674478:T:A | F23L | 0.861 |
| 2:97674478:T:G | F23L | 0.861 |
| 2:97701187:T:C | L183P | 0.860 |
| 2:97701220:C:A | A194D | 0.857 |
| 2:97702701:T:C | F233S | 0.855 |
| 2:97702724:T:A | W241R | 0.851 |
| 2:97702724:T:C | W241R | 0.851 |
| 2:97688904:T:C | L81P | 0.830 |
| 2:97688895:A:T | D78V | 0.820 |
| 2:97701231:G:A | G198R | 0.817 |
| 2:97701231:G:C | G198R | 0.817 |
| 2:97669834:G:C | D16H | 0.801 |
dbSNP variants (sampled 300 via entrez): RS1000071420 (2:97700310 TAC>T), RS1000133220 (2:97698707 A>G), RS1000201297 (2:97671963 C>T), RS1000311706 (2:97679845 AAAAAAAAAG>A), RS1000323352 (2:97679937 G>A,C), RS1000356311 (2:97692398 G>A,C,T), RS1000378252 (2:97687085 C>T), RS1000440380 (2:97686680 A>C), RS1000490502 (2:97668835 G>C), RS1000544961 (2:97681262 T>C), RS1000597155 (2:97681818 A>G), RS1000662484 (2:97680106 C>G), RS1000773208 (2:97687934 C>T), RS1001053876 (2:97674105 C>G,T), RS1001081494 (2:97694579 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 4 |
| Nickel | decreases expression | 2 |
| Valproic Acid | affects cotreatment, decreases expression | 2 |
| bufotalin | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Gold Compounds | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.